The favorable predictive factors identified were: the inclusion of antiangiogenic agents (entire lot), a higher hemoglobin value (entire lot, sub-group of patients with DM, sub-group treated with antiangiogenics), a higher lymphocyte count (in female patients), the inclusion of anti EGFR treatment for patients with DM, a higher creatinine value (in all treatment lines including antiangiogenic agents, as well as in the DM sub-group), and a higher lymphocyte count in treatment lines that included anti EGFR treatment. Here, EGFR is linked to diabetes mellitus.